SeaStar Medical
18 hedge funds and large institutions have $582K invested in SeaStar Medical in 2026 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
19% more capital invested
Capital invested by funds: $489K → $582K (+$92.7K)
6% more funds holding
Funds holding: 17 → 18 (+1)
0.67% more ownership
Funds ownership: 3.29% → 3.97% (+0.67%)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$116K |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$39.6K |
| 3 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
+$16.4K |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$12.2K |
| 5 |
Barclays
London,
United Kingdom
|
+$15 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$58.3K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$23K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$148 |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$133 |
| 5 |
Morgan Stanley
New York
|
-$74 |
ICU Hedge Fund Activity: Q2 2026 in Review
18 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in SeaStar Medical (ICU) for Q2 2026, worth a combined $582K — up 19% from $489K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ICU positions and 1 closed out — a net gain of 2 holders — while 3 added to existing stakes and 4 trimmed.
The largest buyer was UBS Group, adding an estimated $116K. The largest seller was Jane Street, cutting an estimated $58.3K.
- 18 institutional investors held SeaStar Medical (ICU) as of Q2 2026, up from 17 in Q1 2026.
- Funds reported $582K of SeaStar Medical stock for Q2 2026, up 19% quarter-over-quarter.
- 3 funds opened new SeaStar Medical positions in Q2 2026 and 1 closed out, a net change of +2 holders.
- The largest SeaStar Medical buyer in Q2 2026 was UBS Group, an estimated $116K added.
- The largest SeaStar Medical seller in Q2 2026 was Jane Street, an estimated $58.3K sold.
Based on aggregated 13F filings for Q2 2026.